Kadcyla (ado-trastuzumab emtansine) - Roche
Aidixi (disitamab vedotin) - Rongchang Pharma, Seagen
TAA013 - TOT Biopharm
trastuzumab rezetecan (SHR-A1811) - Jiangsu Hengrui Pharma
A166 - Sichuan Kelun Pharma
Perjeta (pertuzumab) - Roche
PF-06804103 - Pfizer
Irene (pyrotinib) - Jiangsu Hengrui Pharma
DP303c - CSPC Pharma
DX126-262 - Hangzhou DAC Biotech
lapatinib - Generic mfg.
anvatabart opadotin (ARX788) - Ambrx
BAT8001 - Bio-Thera Solutions
MRG002 - Lepu Med
https://www.abstractsonline.com/pp8/#!/10828/presentation/10313
 
Herui Yao; Min Yan; Zhongsheng Tong; Xinhong Wu; Min-Hee Ryu; Jee Hyun Kim; John Park; Yahua Zhong; Weiqing Han; Caigang Liu; Mark Voskoboynik; Qun Qin; Jian Zhang; Minal Barve; Ana Acuna-Villaorduna; Vinod Ganju; Seock-Ah Im; Changsheng Ye; Yongmei Yin; Amitesh C. Roy; Li-Yuan Bai; Yung-Chang Lin; Chia-Jui Yen; Hui Li; Ki Young Chung; Shanzhi Gu; Jun Qian; Yuee Teng; Yiding Chen; Yu Shen; Kaijing Zhao; Shangyi Rong; Xiaoyu Zhu; Erwei Song
 
Mar 14, 2023
 
Prev Next